Flora Peyvandi/X
Sep 13, 2025, 01:37
Flora Peyvandi on Iron Deficiency in Mild to Moderate Bleeding Disorders
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown cause: this data highlight the importance of assessing iron status in patients with MBDs, especially in young female individuals …..”
Title: Prevalence of iron deficiency in patients with mild to moderate bleeding disorders and bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Justin Oosterlee, Jasmin Rast, Alexandra Kaider, Helmuth Haslacher, Cihan Ay, Ingrid Pabinger, Johanna Gebhart
Read the full article here.
Find more on Hemostasis Today.
-
May 10, 2026, 00:50Abdulla A. Damluji: Pulsed Field Ablation Delivers a New Standard for Persistent AF
-
May 10, 2026, 00:48Kirti Sharma: Immune Thrombocytopenia Market Set for Strong Growth Through 2036
-
May 10, 2026, 00:41Ram Chaganti: Could Immune Tolerance Be Engineered in Chronic Immune Thrombocytopenia?
-
May 9, 2026, 23:50Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
-
May 9, 2026, 23:37Maia Meier’s Journey: Raising Awareness for Women Living Without a Diagnosis – European Haemophilia Consortium
-
May 9, 2026, 23:13Aakanksha Angra: Building a Community for Advances in ALL
-
May 9, 2026, 22:55Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
-
May 9, 2026, 22:43Simon Ash: Gestational Thrombocytopenia and Maternal Risk at SOAPAM 2026
-
May 9, 2026, 22:18Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery